FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

588311000001103: Lanoxin 125 tablets (GlaxoSmithKline) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16254701000001112 Lanoxin 125 tablets (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
69178501000001112 Lanoxin 125 tablets (Aspen Pharma Trading Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lanoxin 125 tablets (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lanoxin 125 tablets (GlaxoSmithKline) Is a Product containing precisely digoxin 125 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Lanoxin 125 tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lanoxin 125 tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lanoxin 125 tablets (GlaxoSmithKline) Has excipient Lactose false Inferred relationship Existential restriction modifier
Lanoxin 125 tablets (GlaxoSmithKline) Has active ingredient Digoxin false Inferred relationship Existential restriction modifier
Lanoxin 125 tablets (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lanoxin 125 tablets (GlaxoSmithKline) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lanoxin 125 tablets (GlaxoSmithKline) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Lanoxin 125 tablets (GlaxoSmithKline) Is a Lanoxin true Inferred relationship Existential restriction modifier
Lanoxin 125 tablets (GlaxoSmithKline) Has specific active ingredient Digoxin true Inferred relationship Existential restriction modifier
Lanoxin 125 tablets (GlaxoSmithKline) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lanoxin 125 tablets (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lanoxin 125 tablets (GlaxoSmithKline) 500 tablet Is pack of False Lanoxin 125 tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Lanoxin 125 tablets (GlaxoSmithKline) 500 tablet Has AMP True Lanoxin 125 tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start